- Home
- North America Vaccines Market

North America Vaccines Market - Industry Trends and Forecast to 2028
- Published Date: September, 2022 | Report ID: CLS-127 | No of pages: 300 | Format:
North America vaccines market is projected to register a healthy CAGR of 6.6% in the forecast period of 2021 to 2028. The new market report contains data for the historic year 2019, the base year of calculation is 2020 and the forecast period is 2021 to 2028.
Market Segmentation:
North America Vaccines Market, By Composition (Combination Vaccines, Monovaccines), Type (Subunit, Recombinant, Polysaccharide & Conjugate Vaccines, Live-Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, DNA Vaccines), Kind (Routine Vaccine, Recommended Vaccine, Required Vaccine), Age of Administration (Pediatric Vaccine, Adult Vaccine), Diseases (Pneumococcal Disease, Measles, Mumps & Varicella, DPT, Hepatitis, Influenza, Typhoid, Meningococcal, Rabies, Japanese Encephalitis, Yellow Fever, Others), Route of Administration (Injectable, Oral, Nasal), End User (Community Hospitals, Hospitals, Specialty Centres, Clinics, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy),Country (U.S., Canada , Mexico) Industry Trends and Forecast to 2028
Some of the major factors contributing to the growth of North America vaccines market are:
Increasing government support
Presence of pipeline products
Market Players:
The key market players for North America vaccines market are listed below:
Emergent BioSolutions Inc.
Dynavax Technologies
Valneva SE
Bavarian Nordic
Altimmune
Merck Sharp & Dohme Corp (a subsidiary of Merck & Co., Inc.)
Takeda Pharmaceutical Company Limited
Seqirus (a Subsidiary of CSL Limited),
Abbott
AstraZeneca
Sanofi
Pfizer Inc.
Janssen Global Services, LLC (a subsidiary of Johnson & Johnson Services, Inc.)
F. Hoffmann-La Roche Ltd
DAIICHI SANKYO COMPANY, LIMITED
ALK
Panacea Biotec Ltd
BAXTER VACCINES (a subsidiary of Baxter)
GlaxoSmithKline plc.
Serum Institute of India Pvt. Ltd.,
TABLE OF CONTENT
Segmentation
Short Description
North America Vaccines Market, By Composition (Combination Vaccines, Monovaccines), Type (Subunit, Recombinant, Polysaccharide & Conjugate Vaccines, Live-Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, DNA Vaccines), Kind (Routine Vaccine, Recommended Vaccine, Required Vaccine), Age of Administration (Pediatric Vaccine, Adult Vaccine), Diseases (Pneumococcal Disease, Measles, Mumps & Varicella, DPT, Hepatitis, Influenza, Typhoid, Meningococcal, Rabies, Japanese Encephalitis, Yellow Fever, Others), Route of Administration (Injectable, Oral, Nasal), End User (Community Hospitals, Hospitals, Specialty Centres, Clinics, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy),Country (U.S., Canada , Mexico) Industry Trends and Forecast to 2028
Market Definition:
Vaccines are the product that has the capability to reduce the risk of getting a disease by working with the bodys own immune system in order to build up the protection against the deadly pathogens. Various kinds of vaccines have discovered for life threatening diseases which are preventing around 2-3 million deaths every year caused due to diseases such as tetanus, diphtheria, pertussis, measles and influenza among others.
Market Segmentation:
The vaccines market is segmented on the basis of composition, type, kind, age of administration, diseases, route of administration, end user and distribution channel.
On the basis of composition, the vaccines market is segmented into combination vaccines, monovaccines
On the basis of type, the vaccines market is segmented into subunit, recombinant, polysaccharide and conjugate vaccines, live-attenuated vaccines, inactivated vaccines, toxoid vaccines and DNA vaccines
On the basis of kind, the vaccines market is segmented into routine vaccine, recommended vaccine and required vaccine
On the basis of age of administration, the vaccines market is segmented into pediatric vaccine and adult vaccine
On the basis of diseases, the vaccines market is segmented into pneumococcal disease, measles, mumps & varicella, DPT, hepatitis, influenza, typhoid, meningococcal, rabies, Japanese encephalitis, yellow fever and others
On the basis of route of administration, the vaccines market is segmented into injectable, oral and nasal
On the basis of end user, the vaccines market is segmented into community hospitals, hospitals, specialty centres, clinics and others
On the basis of distribution channel, the vaccines market is segmented into hospital pharmacy, retail pharmacy and online pharmacy
Market Players
The key market players for North America vaccines market are listed below:
Emergent BioSolutions Inc.
Dynavax Technologies
Valneva SE
Bavarian Nordic
Altimmune
Merck Sharp & Dohme Corp. (a subsidiary of Merck & Co., Inc.)
Takeda Pharmaceutical Company Limited
Seqirus (a Subsidiary of CSL Limited),
Abbott
AstraZeneca
Sanofi
Pfizer Inc.
Janssen Global Services, LLC (a subsidiary of Johnson & Johnson Services, Inc.)
F. Hoffmann-La Roche Ltd
DAIICHI SANKYO COMPANY, LIMITED
ALK
Panacea Biotec Ltd
BAXTER VACCINES (a subsidiary of Baxter)
GlaxoSmithKline plc.
Serum Institute of India Pvt. Ltd.,
Methodology
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
© 2025 Cognate Lifesciences. All Rights Reserved.